Corporate Separation

Managing corporate separation and meeting regulatory requirements

Scroll Down

THE CLIENT

Fortune 100 diversified medical products and pharmaceuticals organization

STRATEGY

As part of a corporate separation, a Fortune 100 diversified medical products and research-based pharmaceuticals organization needed to separate its PharmacoVigilance (PV) processes and systems between the two new corporate entities.

TRANSFORMATION

Peritius was engaged to manage the separation of the firm’s PV medical functions, PV systems support function, and PV and medical communications systems and data. To support this effort, Peritius:

  • Led and facilitated the decisions regarding which entity would own which system
  • Created a knowledge transfer plan for the PV systems support organization that could be duplicated for any entity that lacked that function

The client required that on Day 1 both corporate entities meet regulatory reporting commitments for drug safety and that transitional service agreements (TSA) were established to provide ongoing operations support through the separation.

RESULT

Both PV organizations were provisioned for short- and long-term success. On Day 1 both corporate entities met regulatory reporting commitments for drug safety. The client’s plan for TSA termination by 24 months after Day 1 was on schedule. All expected benefits were met and the transition office requirements were satisfied.

Back to top
Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

Click to enable/disable Google Analytics tracking code.
Click to enable/disable Google Fonts.
Click to enable/disable Google Maps.
Click to enable/disable video embeds.
Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.